Healthcare provider profile · identity verified

Seth David Levine, D.O

Internal Medicine · COMMERCE TOWNSHIP, MI · NPI 1174754659

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	181
Amlodipine Besylate	Amlodipine Besylate	319	96
Metoprolol Succinate	Metoprolol Succinate	258	68
Levothyroxine Sodium	Levothyroxine Sodium	250	72
Gabapentin	Gabapentin	244	63
Lisinopril	Lisinopril	194	47
Eliquis	Apixaban	188	33
Pantoprazole Sodium	Pantoprazole Sodium	183	62
Hydrochlorothiazide	Hydrochlorothiazide	164	47
Metoprolol Tartrate	Metoprolol Tartrate	153	51
Omeprazole	Omeprazole	153	43
Furosemide	Furosemide	142	59
Azithromycin	Azithromycin	139	79
Simvastatin	Simvastatin	136	39
Losartan Potassium	Losartan Potassium	127	37
Potassium Chloride	Potassium Chloride	123	43
Metformin Hcl	Metformin Hcl	116	35
Warfarin Sodium	Warfarin Sodium	110	12
Hydralazine Hcl	Hydralazine Hcl	109	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	103	54
Rosuvastatin Calcium	Rosuvastatin Calcium	97	29
Allopurinol	Allopurinol	94	27
Lorazepam	Lorazepam	94	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	90	12
Escitalopram Oxalate	Escitalopram Oxalate	87	27
Duloxetine Hcl	Duloxetine Hcl	83	26
Tamsulosin Hcl	Tamsulosin Hcl	80	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	17
Donepezil Hcl	Donepezil Hcl	74	17
Clopidogrel	Clopidogrel Bisulfate	73	25
Tizanidine Hcl	Tizanidine Hcl	73	22
Albuterol Sulfate Hfa	Albuterol Sulfate	71	34
Ropinirole Hcl	Ropinirole Hcl	69	suppressed
Carvedilol	Carvedilol	68	21
Tramadol Hcl	Tramadol Hcl	68	19
Alprazolam	Alprazolam	58	suppressed
Trazodone Hcl	Trazodone Hcl	58	15
Fluticasone Propionate	Fluticasone Propionate	56	27
Pravastatin Sodium	Pravastatin Sodium	55	16
Januvia	Sitagliptin Phosphate	54	15
Prednisone	Prednisone	52	28
Mirtazapine	Mirtazapine	51	16
Montelukast Sodium	Montelukast Sodium	49	16
Methylprednisolone	Methylprednisolone	48	20
Torsemide	Torsemide	46	16
Sertraline Hcl	Sertraline Hcl	45	12
Ezetimibe	Ezetimibe	44	12
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Xarelto	Rivaroxaban	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Spironolactone	Spironolactone	41	14
Topiramate	Topiramate	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	13
Doxycycline Hyclate	Doxycycline Hyclate	40	21
Ozempic	Semaglutide	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	37	13
Atenolol	Atenolol	36	suppressed
Baclofen	Baclofen	35	suppressed
Finasteride	Finasteride	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	17
Synthroid	Levothyroxine Sodium	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	12
Valacyclovir	Valacyclovir Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Levofloxacin	Levofloxacin	26	13
Trintellix	Vortioxetine Hydrobromide	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Famotidine	Famotidine	25	suppressed
Fluconazole	Fluconazole	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Ramipril	Ramipril	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Naproxen	Naproxen	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	12
Lidocaine-Prilocaine	Lidocaine/Prilocaine	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	11
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	13
Ketoconazole	Ketoconazole	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Loperamide	Loperamide Hcl	18	suppressed
Metronidazole	Metronidazole	18	12
Celecoxib	Celecoxib	17	suppressed
Glipizide	Glipizide	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	11
Rybelsus	Semaglutide	17	suppressed
Anastrozole	Anastrozole	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Nystatin	Nystatin	15	11
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Nucynta	Tapentadol Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Valsartan	Valsartan	13	suppressed
Abiraterone Acetate	Abiraterone Acetate	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Colchicine	Colchicine	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error